Organogenesis' (US) product ready for premarket approval (PMA) filing:
This article was originally published in Clinica
Executive Summary
Organogenesis (US) says its PMA for the manufactured human skin product, Graftskin, meets US FDA criteria and has been accepted for filing. It has been granted expedited review by the agency.